What the Changes to CFIUS Mean for Foreign Investment
CFIUS is a U.S. federal interagency committee (“Committee”). The Committee reviews and approves foreign direct investment in U.S.-based businesses. Investment is restricted if it impairs national security. Under the new Foreign Investment Risk Review Modernization Act of 2018 (FIRRMA), what the Committee considers to be “national security” has recently changed to include emerging and critical technologies and sensitive personal data. Additionally, established considerations have been codified into law, and certain mandatory filing requirements have been put in place. As these developments are brand-new, much of the implementing regulatory language has yet to be drafted. What we do know is that a pilot program has been established targeting 27 specific industries, and the penalties for noncompliance can be as high as the value of the deal.
Notably, “Research and Development in Biotechnology” is one of the pilot program industries. It is possible that many life sciences companies could fall under this category and therefore deemed to be involved in the CFIUS pilot program industry. Organizations will need to determine whether they have critical technologies that are subject to the CFIUS pilot program, including items controlled under the Export Administration Regulations (EAR), select agents and toxins, and emerging technologies that will be identified in the coming months.
Mandatory filings are required for certain transactions, starting this month. So what do foreign investors and U.S. parties with potential foreign buyers need to know and do right now?
1. Gather information including:
2. Determine whether a mandatory filing is required:
3. Determine whether a voluntary filing is mandated due to national security concerns such as:
4. Discuss with CFIUS counsel whether the structure of the transaction and the critical technology at issue may fall outside of the CFIUS parameters. This is especially important for financial companies and funds where the structure can determine CFIUS applicability.
5. Start the process as early as possible, and include it as a condition precedent to closing.
Link to article
- Not All Disruptors are Unicorns
- “Text Me?” Proposed Electronic Disclosure Rule Would Allow Greater Flexibility for Retirement Plans
- New Regulation on Location Permit
- 2019 Mergers & Acquisitions Outlook Survey
- Hedge Funds of All Sizes Are Using More Alternative Data, But Not Without Concerns, According to Lowenstein Sandler Survey
- Lowenstein Client Tower International (NYSE: TOWR) Agrees to Acquisition by Autokiniton Global Group in $900 Million Deal
- The Wall Street Journal: Lowenstein Sandler Is One of the Nation’s Top Power Players in Large Corporate Bankruptcies
WSG Member: Please login to add your comment.